Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Identification of HIV integrase inhibitor BMS-727740 described by Bristol-Myers Squibb

Aug. 30, 2010

LIM-0705 reverses tacrolimus-induced metabolic defects in phase Ib trial

Aug. 27, 2010

DIDS improves yield and preserves integrity of isolated pancreatic islets

Aug. 27, 2010

NGP-328 is selected as clinical candidate for Alzheimer's disease

Aug. 27, 2010

Researchers describe new anti-inflammatory MAPK 14 inhibitors

Aug. 27, 2010

Netupitant shows promise to treat overactive bladder in preclinical studies

Aug. 27, 2010

New adenosylhomocysteinase inhibitors show preclinical potential to treat AD

Aug. 26, 2010

Scientists present preclinical data on new HCV NS4A antagonists at ACS meeting

Aug. 26, 2010

New SGLT-2 inhibitor CSG-452 is selected as clinical candidate

Aug. 26, 2010

SAR-106881, an FGFR agonist derived from FGFR antagonists

Aug. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...